Journal of Correctional Health Care - April 2023 - 107

PRESCRIBING PSYCHOTROPIC MEDICATIONS
107
Norton, A. A. (2012). The captive mind: Antipsychotics as chemical restraint
in juvenile detention. Journal of Contemporary Health Law and Policy,
29(1), 152-182. https://www.ncbi.nlm.nih.gov/pubmed/23424905
Office of Juvenile Justice and Delinquency Prevention. (2009). Juvenile arrests
2009. https://www.ojjdp.gov/ojstatbb/crime/qa05101.asp?qaDate=
2009&text=yes
Office of Juvenile Justice and Delinquency Prevention. (2017). Time in
placement 2017. https://www.ojjdp.gov/ojstatbb/corrections/qa08405
.asp?qaDate=2017
Office of Juvenile Justice and Delinquency Prevention. (2019a). Juvenile
arrests 2019. https://www.ojjdp.gov/ojstatbb/crime/qa05101
.asp?qaDate=2019
Office of Juvenile Justice and Delinquency Prevention. (2019b). Juveniles in
adult jails and prisons. https://www.ojjdp.gov/ojstatbb/corrections/
qa08700.asp
Office of Juvenile Justice and Delinquency Prevention. (2019c). One day
count of juveniles in residential placement facilities, 1997-2018. https://
www.ojjdp.gov/ojstatbb/corrections/qa08201.asp
Penn, J. V., Esposito, C. L., Schaeffer, L. E., Fritz, G. K., & Spirito, A. (2003).
Suicide attempts and self-mutilative behavior in a juvenile correctional
facility. Journal of the American Academy of Child and Adolescent Psychiatry,
42(7), 762-769. https://doi.org/10.1097/01.CHI.0000046869
.56865.46
Penn, J. V., & Thomas, C. (2005). Practice parameter for the assessment and
treatment of youth in juvenile detention and correctional facilities
[AACAP official action]. Journal of the American Academy of Child and
Adolescent Psychiatry, 44(10), 1085-1098. https://doi.org/10.1097/01.chi
.0000175325.14481.21
Popper, C. W. (2014). Single-micronutrient and broad-spectrum micronutrient
approaches for treating mood disorders in youth and adults.
Child and Adolescent Psychiatric Clinics of North America, 23(3), 591-672.
https://doi.org/10.1016/j.chc.2014.04.001
Post, S., Spiller, H. A., Casavant, M. J., Chounthirath, T., & Smith, G. A. (2018).
Buprenorphine exposures among children and adolescents reported to
US poison control centers. Pediatrics, 142(1), e20173652. https://doi.org/
10.1542/peds.2017-3652
Pringsheim, T., Hirsch, L., Gardner, D., & Gorman, D. A. (2015). The pharmacological
management of oppositional behaviour, conduct problems,
and aggression in children and adolescents with attention-deficit hyperactivity
disorder, oppositional defiant disorder, and conduct disorder:
A systematic review and meta-analysis. Part 1: Psychostimulants, alpha-2
agonists, and atomoxetine. Canadian Journal of Psychiatry, 60(2), 42-51.
https://doi.org/10.1177/070674371506000202
Prison Rape Elimination Act. (2003). x 42 U.S.C. ch. 147 x 15601 et seq..
Ramsay Wan, C., Broussard, B., Haggard, P., & Compton, M. T. (2014).
Criminal justice settings as possible sites for early detection of psychotic
disorders and reducing treatment delay. Psychiatric Services, 65(6), 758-
764. https://doi.org/10.1176/appi.ps.201300206
Raskind, M. H., Goldberg, R. J., Higgins, E. L., & Herman, K. L. (1999). Patterns
of change and predictors of success in individuals with learning disabilities:
Results from a twenty-year longitudinal study. Learning Disabilities
Research & Practice, 14(1), 35-49. https://doi.org/10.1207/
sldrp1401_4
Retz, W., Ginsberg, Y., Turner, D., Barra, S., Retz-Junginger, P., Larsson, H., &
Asherson, P. (2021). Attention-deficit/hyperactivity disorder (ADHD),
antisociality and delinquent behavior over the lifespan. Neuroscience &
Biobehavioral Reviews, 120, 236-248. https://doi.org/10.1016/j.neubiorev
.2020.11.025
Ro¨ sler, M., Retz, W., Retz-Junginger, P., Hengesch, G., Schneider, M.,
Supprian, T., Schwitzgebel, P., Pinhard, K., Dovi-Akue, N., Wender, P., &
Thome, J. (2004). Prevalence of attention deficit-/hyperactivity disorder
(ADHD) and comorbid disorders in young male prison inmates. European
Archives of Psychiatry and Clinical Neuroscience, 254(6), 365-371. https://
doi.org/10.1007/s00406-004-0516-z
Rugino, T. A. (2018). Effect on primary sleep disorders when children with
ADHD are administered guanfacine extended release. Journal of
Attention Disorders, 22(1), 14-24. https://doi.org/10.1177/10870547
14554932
Rutten, A. X., Vermeiren, R. R. J. M., & Van Nieuwenhuizen, C. (2017). Autism
in adult and juvenile delinquents: A literature review. Child and Adolescent
Psychiatry and Mental Health, 11, 45. https://doi.org/10.1186/s13034017-0181-4
Sabus,
A., Feinstein, J., Romani, P., Goldson, E., & Blackmer, A. (2019).
Management of self-injurious behaviors in children with neurodevelopmental
disorders: A pharmacotherapy overview. Pharmacotherapy,
39(6), 645-664. https://doi.org/10.1002/phar.2238
Sickmund, M., & Puzzanchera, C. (Eds.). (2014). Juvenile offenders and victims:
2014 national report. National Center for Juvenile Justice. https://www
.ojjdp.gov/ojstatbb/nr2014/downloads/chapter3.pdf
Sikorski, J. B. (1991). Learning disorders and the juvenile justice system.
Psychiatric Annals, 21(12), 742-747. https://doi.org/10.3928/0048-571319911201-10
Steiner,
H., & Remsing, L. (2007). Practice parameter for the assessment and
treatment of children and adolescents with oppositional defiant disorder
[AACAP official action]. Journal of the American Academy of Child and
Adolescent Psychiatry, 46(1), 126-141. https://doi.org/10.1097/01.chi
.0000246060.62706.af
Stepanova, E., & Findling, R. L. (2017). Psychopharmacology of bipolar disorders
in children and adolescents. Pediatric Clinics of North America,
64(6), 1209-1222. https://doi.org/10.1016/j.pcl.2017.08.002
Strawn, J., & Keeshin, B. (2019). Pharmacotherapy for posttraumatic stress
disorder in children and adolescents. UpToDate. https://www.uptodate
.com/contents/pharmacotherapy-for-posttraumatic-stress-disorder-inchildren-and-adolescents
Syed,
S. A., Dixson, B. A., Constantino, E., & Regan, J. (2021). The law and
practice of off-label prescribing and physician promotion. Journal of the
American Academy of Psychiatry and the Law, 49(1), 53-59. https://doi
.org/10.29158/JAAPL.200049-20
Symons, F. J., Thompson, A., & Rodriguez, M. C. (2004). Self-injurious behavior
and the efficacy of naltrexone treatment: A quantitative synthesis.
Mental Retardation and Developmental Disabilities Research Reviews, 10(3),
193-200. https://doi.org/10.1002/mrdd.20031
Tamburello, A., Lieberman, J. A., Baum, R. M., & Reeves, R. (2012). Successful
removal of quetiapine from a correctional formulary. Journal of the
American Academy ofPsychiatry and the Law, 40(4), 502-508. https://jaapl
.org/content/46/2_Supplement/S2
Tamburello, A., Penn, J., Ford, E., Champion, M. K., Glancy, G., Metzner, J.,
Ferguson, E., Tomita, T., & Ourada, J. (2022). The American Academy of
Psychiatry and the Law practice resource for prescribing in corrections.
Journal of the American Academy of Psychiatry and the Law, 50(4) Supplement,
S1-S62. https://jaapl.org/content/jaapl/50/4_Supplement/S1
.full.pdf
Texas Health and Human Services Commission. (2019). Psychotropic medication
utilization parameters for children and youth in Texas public behavioral
health (6th version). https://www.hhs.texas.gov/sites/default/files/
documents/doing-business-with-hhs/provider-portal/facilities-regulation/
psychiatric/psychotropic-medication-utilization-parameters.pdf
Thomas, C. R., & Holzer, C. E., 3rd. (1999). National distribution of child and
adolescent psychiatrists. Journal of the American Academy of Child and
Adolescent Psychiatry, 38(1), 9-16. https://doi.org/10.1097/00004583199901000-00013
Tourian,
L., LeBoeuf, A., Breton, J. J., Cohen, D., Gignac, M., Labelle, R., Guile,
J. M., & Renaud, J. (2015). Treatment options for the cardinal symptoms of
disruptive mood dysregulation disorder. Journal of the Canadian Academy
of Child and Adolescent Psychiatry, 24(1), 41-54.
Turgay, A. (2009). Psychopharmacological treatment of oppositional defiant
disorder. CNS Drugs, 23(1), 1-17. https://doi.org/10.2165/0023210200923010-00001
Umpierre,
M. (2014). Rights and responsibilities of youth, families, and staff.
In Desktop guide to quality practice for working with youth in confinement.
National Partnership for Juvenile Services and Office of Juvenile Justice
and Delinquency Prevention. https://info.nicic.gov/dtg/node/11
Underwood, L. A., & Washington, A. (2016). Mental illness and juvenile offenders.
International Journal of Environmental Research and Public
Health, 13(2), 228. https://doi.org/10.3390/ijerph13020228
United States Department of Justice. (2012). Prison Rape Elimination Act:
Juvenile facility standards. United States Department of Justice final rule.
https://www.prearesourcecenter.org/sites/default/files/library/
preafinalstandardstype-juveniles.pdf
U.S. Food & Drug Administration. (2021, December 27). Supplemental approval
fulfillment of postmarketing requirement (NDA 205422/S-007) [for
brexpiprazole]. https://www.accessdata.fda.gov/drugsatfda_docs/
appletter/2021/205422Orig1s007ltr.pdf
Villagomez, A., & Ramtekkar, U. (2014). Iron, magnesium, vitamin D, and zinc
deficiencies in children presenting with symptoms of attention-deficit/
hyperactivity disorder. Children, 1(3), 261-279. https://doi.org/10.3390/
children1030261
Volkmar, F., Cook, E., Jr., Pomeroy, J., Realmuto, G., & Tanguay, P. (1999).
Summary of the practice parameters for the assessment and treatment of
children, adolescents, and adults with autism and other pervasive developmental
disorders [AACAP official action]. American Academy of
Child and Adolescent Psychiatry. Journal of the American Academy of
Journal of Correctional Health Care - April 2023

Table of Contents for the Digital Edition of Journal of Correctional Health Care - April 2023
